Zobrazeno 1 - 2
of 2
pro vyhledávání: '"G. L. S. Kam"'
Publikováno v:
Internal Medicine Journal. 41:191-196
Background/Aim: JAK2V617F is an acquired mutation present in a considerable proportion of patients with chronic myeloproliferative disorders. Its reported prevalence in European and US studies of patients with essential thrombocythaemia (ET) is 23–
Publikováno v:
Internal medicine journal. 41(2)
JAK2V617F is an acquired mutation present in a considerable proportion of patients with chronic myeloproliferative disorders. Its reported prevalence in European and US studies of patients with essential thrombocythaemia (ET) is 23-57%. This study wa